United States · Funded startup
5 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$51Mraised across 5 rounds since 2005, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $100K sold, first sale Dec 2014
Connecticut Innovations
Rho Capital Partners
Alta Partners
MVM Life Science Partners
FLAG Capital Management, LLCReported by fiercebiotech.comSEC filing: $4.8M sold, first sale Jul 2010
Connecticut InnovationsFrom a historical funding record
Mitsubishi UFJ CapitalAlta PartnersMVM Life Science PartnersFLAG Capital Management, LLCReported by thefreelibrary.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Connecticut InnovationsAlta PartnersMVM Life Science PartnersDevon Park BioVenturesFLAG Capital Management, LLCMitsubishi UFJ CapitalRho Capital PartnersMitsubishi Corporation Life Sciences VentureMissing a round, or an investor who was in one? Tell us.
Cara Therapeutics's investors include Ascent Biomedical Ventures, Connecticut Innovations, Alta Partners, MVM Life Science Partners and Devon Park BioVentures, and 6 more on record.
Cara Therapeutics has raised $51M across 5 rounds since 2005.
Cara Therapeutics's most recent round was an Undisclosed round of $100K in Dec 2014.
Cara Therapeutics's largest round on record is $19M (Series C), in Nov 2006.
Cara Therapeutics's first round on record, in Dec 2005, was backed by Ascent Biomedical Ventures and Esperante Ventures.
Cara Therapeutics's latest named round is an Undisclosed round, in Dec 2014.
Cara Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·